🔎 Trials Near Me

Akèy › Melanom Uveal › New York

Etid klinik pou Melanom Uveal nan New York

7 etid pou Melanom Uveal ap chèche patisipan nan sit nan New York.

Vil nan New York

Tèks ofisyèl etid la (Anglè)

A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma

  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT05607095

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

  • Memorial Sloan Kettering Cancer Center, New York
  • Northwell Health, New York
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07804186

Adjuvant Tebentafusp in High Risk Ocular Melanoma

  • Northwell Health -Center for Advanced Medicine, Lake Success
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jun 30, 2026 · NCT06246149

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

  • Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou May 13, 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

  • Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
  • Northwell Health Cancer Institute, New York
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 6, 2026 · NCT07015190

Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma

  • Northwell Health Center for Advanced Medicine, New Hyde Park
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 4, 2025 · NCT06121180

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.